BA3182

· BioAtla, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BA3182, covering 2025-09-25 to 2025-09-25. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma. [Phase 1]